Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Funicelli

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Annals of Surgical Oncology|September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver MetastasesEmilio Bertani, Nicola Fazio, Davide Radice, et al.
Langenbeck'S Archives of Surgery|February 16, 2024
Diagnosis and staging of small intestinal neuroendocrine tumors with CT enterography and PET with Gallium-68: preoperative risk stratification protocolAlessandro Bonomi, Uberto Fumagalli Romario, Luigi Funicelli, et al.
Targeted Oncology|June 22, 2017
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine TumorsDiana Martins, Francesca Spada, Ioana Lambrescu, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2017
<i>Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice</i>: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine NeoplasmsFranco Grimaldi, Nicola Fazio, Roberto Attanasio, et al.
Cancer Treatment Reviews|March 18, 2017
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectivesIoana Lambrescu, Simona Fica, Diana Martins, et al.
Tumori|August 1, 2020
Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapyDario Zerini, Filippo Patti, Francesca Spada, et al.
Cancers|September 23, 2022
Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical OutcomesChiara Alessandra Cella, Francesca Spada, Alfredo Berruti, et al.
Journal of Thoracic Disease|December 5, 2017
The role of multimodal treatment in patients with advanced lung neuroendocrine tumorsNicola Fazio, Antonio Ungaro, Francesca Spada, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2021
First <i>Ex Vivo</i> Results of β<sup>-</sup>-Radioguided Surgery in Small Intestine Neuroendocrine Tumors with <sup>90</sup>Y-DOTATOCEmilio Bertani, Francesco Collamati, Marzia Colandrea, et al.
Cancers|October 14, 2022
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center SeriesNicola Fazio, Patrick Maisonneuve, Francesca Spada, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver MetastasesEmilio Bertani, Nicola Fazio, Davide Radice, et al.
Langenbeck'S Archives of Surgery|February 16, 2024
Diagnosis and staging of small intestinal neuroendocrine tumors with CT enterography and PET with Gallium-68: preoperative risk stratification protocolAlessandro Bonomi, Uberto Fumagalli Romario, Luigi Funicelli, et al.
Targeted Oncology|June 22, 2017
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine TumorsDiana Martins, Francesca Spada, Ioana Lambrescu, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2017
<i>Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice</i>: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine NeoplasmsFranco Grimaldi, Nicola Fazio, Roberto Attanasio, et al.
Cancer Treatment Reviews|March 18, 2017
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectivesIoana Lambrescu, Simona Fica, Diana Martins, et al.
Tumori|August 1, 2020
Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapyDario Zerini, Filippo Patti, Francesca Spada, et al.
Cancers|September 23, 2022
Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical OutcomesChiara Alessandra Cella, Francesca Spada, Alfredo Berruti, et al.
Journal of Thoracic Disease|December 5, 2017
The role of multimodal treatment in patients with advanced lung neuroendocrine tumorsNicola Fazio, Antonio Ungaro, Francesca Spada, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2021
First <i>Ex Vivo</i> Results of β<sup>-</sup>-Radioguided Surgery in Small Intestine Neuroendocrine Tumors with <sup>90</sup>Y-DOTATOCEmilio Bertani, Francesco Collamati, Marzia Colandrea, et al.
Cancers|October 14, 2022
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center SeriesNicola Fazio, Patrick Maisonneuve, Francesca Spada, et al.
Pageof 3